ABUS · Company research

Arbutus Biopharma Corporation Common Stock (ABUS): Stock News & Events

Recent company-linked news records available in the database.

RESEARCH CONTEXT

Understand the numbers

Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.

14records availableHealthcare

Stock News & Events data

Database-backed records only

14 rows
titlesummaryurlsourcepublished atsentimentsentiment scorerelevance score
Morgan Stanley reports owning more than 10% of Arbutus Biopharma (ABUS) in an amendment. - Stock TitanMorgan Stanley reports owning more than 10% of Arbutus Biopharma (ABUS) in an amendment. Stock TitanView source ↗Stock TitanOct 7, 2026neutral00.6
ABUS Stock Price, Quote & Chart - ChartMillABUS Stock Price, Quote & Chart ChartMillView source ↗ChartMillOct 6, 2026neutral00.6
At $5 a share, Arbutus Biopharma (ABUS) accepts tendered shares; Roivant retains about 19.5%. - Stock TitanAt $5 a share, Arbutus Biopharma (ABUS) accepts tendered shares; Roivant retains about 19.5%. Stock TitanView source ↗Stock TitanOct 6, 2026neutral00.6
About 23% of Arbutus shares are being bought back for $230 million. - Stock TitanAbout 23% of Arbutus shares are being bought back for $230 million. Stock TitanView source ↗Stock TitanOct 1, 2026neutral00.6
ABUS Stock Surges 10% Today — What’s Driving This Super Rally? - StocktwitsABUS Stock Surges 10% Today — What’s Driving This Super Rally? StocktwitsView source ↗StocktwitsAug 21, 2026neutral00.6
ABUS Stock Pops As Moderna Settlement Transforms Balance Sheet - StocksToTradeABUS Stock Pops As Moderna Settlement Transforms Balance Sheet StocksToTradeView source ↗StocksToTradeAug 21, 2026neutral00.6
ABUS Stock Surges 10% Today — What’s Driving This Super Rally? - Yahoo FinanceABUS Stock Surges 10% Today — What’s Driving This Super Rally? Yahoo FinanceView source ↗Yahoo FinanceAug 21, 2026neutral00.6
Arbutus (NASDAQ: ABUS) plans Dutch auction share buyback - Stock TitanArbutus (NASDAQ: ABUS) plans Dutch auction share buyback Stock TitanView source ↗Stock TitanAug 21, 2026neutral00.6
Arbutus Biopharma (ABUS) Stock Profit Surge Leaves Durability Questions Open - Simply Wall StreetArbutus Biopharma (ABUS) Stock Profit Surge Leaves Durability Questions Open Simply Wall StreetView source ↗Simply Wall StreetAug 12, 2026neutral00.6
ABUS Stock On Track For Best Day In About Two Months — What’s The Moderna Connection? - StocktwitsABUS Stock On Track For Best Day In About Two Months — What’s The Moderna Connection? StocktwitsView source ↗StocktwitsJul 16, 2026neutral00.6
Arbutus Biopharma: Moderna Validates My IP Bull Case (NASDAQ:ABUS) - Seeking AlphaArbutus Biopharma: Moderna Validates My IP Bull Case (NASDAQ:ABUS) Seeking AlphaView source ↗Seeking AlphaJul 13, 2026neutral00.6
Arbutus Biopharma (ABUS) Stock Looks Reasonable On Earnings But Stretched On Value - Simply Wall StreetArbutus Biopharma (ABUS) Stock Looks Reasonable On Earnings But Stretched On Value Simply Wall StreetView source ↗Simply Wall StreetJul 9, 2026neutral00.6
ABUS Stock Rallies Ahead Of Big Payout From Moderna Settlement This Week - Yahoo FinanceABUS Stock Rallies Ahead Of Big Payout From Moderna Settlement This Week Yahoo FinanceView source ↗Yahoo FinanceJul 7, 2026neutral00.6
Arbutus Biopharma Corp ($ABUS) Former Interim President and CEO 2025 Pay Revealed - Quiver QuantitativeArbutus Biopharma Corp ($ABUS) Former Interim President and CEO 2025 Pay Revealed Quiver QuantitativeView source ↗Quiver QuantitativeApr 15, 2026neutral00.6

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.